Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human GPR20 Stable Cell Line

    [CAT#: S01YF-0923-PY182]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    GPR20
    Target Family
    Orphan Family
    Target Protein Species
    Rat
    Host Cell Type
    PC12h;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    CNS Research;Ocular Research
    Related Diseases
    Retinitis Pigmentosa 11;Polycystic Kidney Disease 2 With Or Without Polycystic Liver Disease
    Gene ID
    Rat: 60667

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    GPR20, a G-protein coupled receptor, has been a subject of interest in scientific research, though its specific roles and functions are still being elucidated. While direct studies on GPR20 were limited in the search, G-protein coupled receptors (GPCRs) are known to play crucial roles in various physiological processes, including signal transduction pathways. These receptors are often targeted in drug development due to their involvement in many diseases. Further research on GPR20 could provide insights into its potential therapeutic applications and its role in various physiological and pathological processes.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human GPR20 Stable Cell Line (S01YF-0923-PY182). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Deborah (Verified Customer)

    What is the significance of GPR20 in cellular research? Sep 19 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    GPR20 is a class-A orphan G protein-coupled receptor (GPCR) that has been recognized as a potential therapeutic target for gastrointestinal stromal tumors (GIST) due to its differentially high expression. It's identified as a novel non-tyrosine kinase target in GIST, with its expression being assessed in cell lines, patient-derived xenografts, and clinical samples in research studies​. Sep 19 2021

    chat James (Verified Customer)

    How can GPR20 be studied through stable cell line products? Mar 18 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Stable cell line products like the Panoply™ Human GPR20 Knockdown Stable Cell Line can be utilized for functional genomics research and drug discovery studies. These stable cell lines offer a controlled environment to study the functions and interactions of GPR20, and can be instrumental in drug screening and understanding the receptor's signaling pathways, which may be essential for developing therapeutic strategies in diseases like GIST​​. Mar 18 2023

    Published Data

    Fig.1 rGPR20 silencing effects on baseline cAMP levels

    In the experiment, PC12h cells were subjected to transfection with three distinct rGPR20-shRNA plasmids (designated as pSilencer-sh1, -sh2, and -sh3), alongside control shRNA plasmids. The study focused on examining the impact of rGPR20 silencing on the baseline cAMP levels within these cells. The provided results represent the means ± standard error (S.E.) derived from a single representative trial out of two separate, quadruplicate experiments. Statistical analysis, conducted using ANOVA coupled with Tukey's multiple comparison test, revealed significant differences denoted by asterisks (*), with p-values less than 0.05.

    Ref: Hase, Momoko, et al. "Characterization of an orphan G protein-coupled receptor, GPR20, that constitutively activates Gi proteins." Journal of Biological Chemistry 283.19 (2008): 12747-12755.

    Pubmed: 18347022

    DOI: 10.1074/jbc.M709487200

    Research Highlights

    George S, et al. "A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients ." Clinical cancer research : an official journal of the American Association for , 2023.
    DS-6157a, an antibody-drug conjugate targeting G protein-coupled receptor 20 (GPR20), was evaluated in patients with gastrointestinal stromal tumors (GIST) in a phase I multicenter, open-label, multiple-dose study. The primary objective was to assess the safety and tolerability of DS-6157a and determine the maximum tolerated dose (MTD). Secondary objectives included examining plasma pharmacokinetics, antidrug antibodies (ADA), and efficacy. Thirty-four patients were enrolled, and DS-6157a was found to be well-tolerated with DLTs observed in 4 patients (11.8%) at doses of 6.4 mg/kg, 9.6 mg/kg, and 12.8 mg/kg. The MTD was determined to be 6.4 mg/kg. Treatment-emergent adverse events (TEAE) occurred in 17 patients (50.0%), with four patients (11.8%) experiencing serious adverse events related to DS-6157a. Tumor shrinkage was observed in 20.6% of patients, and 2.9% achieved a partial response. Plasma concentrations of intact DS-6157a, DXd, and total anti-GPR20 antibody showed a dose-dependent profile. No treatment-emergent ADAs were observed. While DS-6157a showed promising results in targeting GPR20 in patients with advanced GIST, it did not proceed further due to lower efficacy outcomes than anticipated.
    Pubmed: 37363962   DOI: 10.1158/1078-0432.CCR-23-0640

    Persichilli C, et al. "Exploring genome-wide differentiation and signatures of selection in Italian and ." Journal of dairy science, 2023.
    In this study, a medium-density genome-wide data set consisting of 79,464 imputed SNPs was used to examine the genetic structure of the Italian Holstein breed, specifically the population reared in the region of Parmigiano Reggiano protected designation of origin cheese production. Multidimensional scaling and ADMIXTURE approaches were employed to investigate the genetic relationships among three Holstein populations: Italian, North American, and Parmigiano Reggiano. Furthermore, four different statistical methods were used to identify putative genomic regions under selection in these populations, including those related to milk quality, resistance to disease, and fertility. The results revealed clear genetic distinctions between the three populations, with the most significant difference being observed between the Italian and North American stock. Additionally, 22 genes related to milk production were identified through allele frequency approaches, with the VPS8 gene showing evidence of convergent selection. Seven genomic regions containing candidate genes for milk traits were also identified through extended haplotype homozygosity analyses. These findings provide important insights into the genetic diversity and selective pressures among these Holstein populations, and may have practical implications for future breeding and selection strategies.
    Pubmed: 37291034   DOI: 10.3168/jds.2022-22159

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare